Please login to the form below

Not currently logged in
Email:
Password:

Professor Thomas Cech joins Storm Therapeutics

He takes up a scientific advisor role at the group

Thomas CechStorm Therapeutics, a company focused on the discovery of small molecule therapies has appointed Professor Thomas Cech as its scientific advisor.

Professor Cech’s career has seen him spend decades researching into RNA biology and he became the scientific founder of Ribozyme Pharmaceuticals. He currently serves on the board of directors of Merck & Co.

Commenting on the new appointments, Keith Blundy, chief executive officer of Storm Therapeutics, said: “We are very pleased to have attracted such an internationally renowned researcher as Professor Cech to Storm.

“As a leader in the field of RNA biology, Tom’s in-depth knowledge, insight and experience will be invaluable as we look to continue building a drug discovery platform and mature into a world leading therapeutics company targeting RNA epigenetic modulation.”

His new role will see him join recent hires Professor Mark Dawson and Dr Paul Leeson to boost Storm’s pipeline.

9th February 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics